(VIANEWS) – Cherry Hill Mortgage Investment Corporation (CHMI), Nuveen Global High Income Fund (JGH), ClearBridge Energy MLP Opportunity Fund (EMO) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Cherry Hill Mortgage Investment Corporation (CHMI) | 14.46% | 2023-09-21 07:14:07 |
| Nuveen Global High Income Fund (JGH) | 10.89% | 2023-09-23 01:08:07 |
| ClearBridge Energy MLP Opportunity Fund (EMO) | 8.02% | 2023-09-21 23:08:06 |
| First Trust MLP and Energy Income Fund (FEI) | 7.39% | 2023-09-22 04:41:07 |
| Bristol (BMY) | 4.02% | 2023-10-08 03:17:18 |
| Diageo (DEO) | 2.76% | 2023-10-08 03:18:01 |
| Eastern Company (EML) | 2.44% | 2023-09-27 19:15:06 |
| Abbott Laboratories (ABT) | 2.11% | 2023-10-08 03:16:45 |
| Flowserve Corporation (FLS) | 2.05% | 2023-09-22 05:23:08 |
Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Cherry Hill Mortgage Investment Corporation (CHMI) – Dividend Yield: 14.46%
Cherry Hill Mortgage Investment Corporation’s last close was $4.15, 42.68% below its 52-week high of $7.24. Intraday change was 1.47%.
Cherry Hill Mortgage Investment Corporation, a residential real estate finance company, acquires, invests in, and manages residential mortgage assets in the United States. The company operates through Investments in RMBS, Investments in Servicing Related Assets, and All Other segments. It manages a portfolio of servicing related assets and residential mortgage-backed securities (RMBS). The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. Cherry Hill Mortgage Investment Corporation was incorporated in 2012 and is based in Farmingdale, New Jersey.
Earnings Per Share
As for profitability, Cherry Hill Mortgage Investment Corporation has a trailing twelve months EPS of $-0.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -3.39%.
Sales Growth
Cherry Hill Mortgage Investment Corporation’s sales growth for the current quarter is 111.6%.
Moving Average
Cherry Hill Mortgage Investment Corporation’s value is above its 50-day moving average of $4.08 and way under its 200-day moving average of $5.31.
Yearly Top and Bottom Value
Cherry Hill Mortgage Investment Corporation’s stock is valued at $4.15 at 20:15 EST, way under its 52-week high of $7.24 and way above its 52-week low of $3.70.
More news about Cherry Hill Mortgage Investment Corporation.
2. Nuveen Global High Income Fund (JGH) – Dividend Yield: 10.89%
Nuveen Global High Income Fund’s last close was $11.40, 10.24% below its 52-week high of $12.70. Intraday change was -0.09%.
Nuveen Global High Income Fund is a closed-ended fixed income mutual fund launched by Nuveen Investments, Inc. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC. It invests in fixed income markets across the globe. The fund primarily invests in U.S. high-yield bonds, non-U.S. high-yield bonds from developed and emerging markets, corporate debt securities, U.S. and foreign government debt securities, mortgage and asset-backed securities, preferred securities, secured and unsecured loans, and convertible debt securities. It seeks to invest in below investment grade securities rated BB/Ba or lower. The fund uses a diversified global high-income strategy, which blends high-yield bonds and other income producing securities from around the world, and across the capital structure and credit spectrum, to create its portfolio. It benchmarks the performance of its portfolio against the Barclays Global High Yield Index. Nuveen Global High Income Fund was formed on August 5, 2014 and is domiciled in the United States.
Earnings Per Share
As for profitability, Nuveen Global High Income Fund has a trailing twelve months EPS of $1.37.
PE Ratio
Nuveen Global High Income Fund has a trailing twelve months price to earnings ratio of 8.32. Meaning, the purchaser of the share is investing $8.32 for every dollar of annual earnings.
Volume
Today’s last reported volume for Nuveen Global High Income Fund is 165134 which is 214.09% above its average volume of 52575.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Sep 13, 2023, the estimated forward annual dividend rate is 1.24 and the estimated forward annual dividend yield is 10.89%.
Moving Average
Nuveen Global High Income Fund’s worth is under its 50-day moving average of $11.51 and below its 200-day moving average of $11.41.
More news about Nuveen Global High Income Fund.
3. ClearBridge Energy MLP Opportunity Fund (EMO) – Dividend Yield: 8.02%
ClearBridge Energy MLP Opportunity Fund’s last close was $32.04, 2.38% under its 52-week high of $32.82. Intraday change was -0.77%.
ClearBridge Energy MLP Opportunity Fund Inc. is a closed ended equity mutual fund launched and managed by Legg Mason Partners Fund Advisor, LLC. It is co-managed by ClearBridge Investments, LLC. The fund invests in the public equity markets of the United States. It seeks to invest in stocks of companies operating in the energy sector. The fund primarily invests in equity securities of MLPs with operations in crude oil, natural gas liquids, and refined products infrastructure. It seeks to invest in companies with long-lived assets, predictable cash flows, and relatively low direct commodity exposure to create its portfolio. ClearBridge Energy MLP Opportunity Fund Inc. was formed on April 5, 2011 and is domiciled in the United States.
Earnings Per Share
As for profitability, ClearBridge Energy MLP Opportunity Fund has a trailing twelve months EPS of $-2.76.
Yearly Top and Bottom Value
ClearBridge Energy MLP Opportunity Fund’s stock is valued at $32.04 at 20:15 EST, below its 52-week high of $32.82 and way higher than its 52-week low of $23.31.
Volume
Today’s last reported volume for ClearBridge Energy MLP Opportunity Fund is 46764 which is 74.01% above its average volume of 26873.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 22, 2023, the estimated forward annual dividend rate is 2.6 and the estimated forward annual dividend yield is 8.02%.
Moving Average
ClearBridge Energy MLP Opportunity Fund’s worth is higher than its 50-day moving average of $31.53 and higher than its 200-day moving average of $29.53.
More news about ClearBridge Energy MLP Opportunity Fund.
4. First Trust MLP and Energy Income Fund (FEI) – Dividend Yield: 7.39%
First Trust MLP and Energy Income Fund’s last close was $8.07, 4.04% below its 52-week high of $8.41. Intraday change was -0.62%.
First Trust MLP and Energy Income Fund is a closed-ended balanced mutual fund launched and managed by First Trust Advisors L.P. The fund is co-managed by Energy Income Partners LLC. It invests in the public equity and fixed income markets of the United States. The fund seeks to invest in securities of companies operating in the energy and energy utilities sectors. It primarily invests in equity and debt securities of MLPs and MLP-related entities, as well as in dividend paying growth stocks of companies. First Trust MLP and Energy Income Fund was formed on August 17, 2012 and is domiciled in the United States.
Earnings Per Share
As for profitability, First Trust MLP and Energy Income Fund has a trailing twelve months EPS of $0.58.
PE Ratio
First Trust MLP and Energy Income Fund has a trailing twelve months price to earnings ratio of 13.91. Meaning, the purchaser of the share is investing $13.91 for every dollar of annual earnings.
Volume
Today’s last reported volume for First Trust MLP and Energy Income Fund is 42586 which is 53.59% below its average volume of 91779.
More news about First Trust MLP and Energy Income Fund.
5. Bristol (BMY) – Dividend Yield: 4.02%
Bristol’s last close was $56.66, 30.43% below its 52-week high of $81.44. Intraday change was 0.27%.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $3.76.
PE Ratio
Bristol has a trailing twelve months price to earnings ratio of 15.05. Meaning, the purchaser of the share is investing $15.05 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.66%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.6%, now sitting on 45.19B for the twelve trailing months.
Moving Average
Bristol’s value is below its 50-day moving average of $60.22 and way below its 200-day moving average of $66.28.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is a negative 9.5% and a negative 1.1%, respectively.
More news about Bristol.
6. Diageo (DEO) – Dividend Yield: 2.76%
Diageo’s last close was $151.68, 20.97% under its 52-week high of $191.93. Intraday change was 0.74%.
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. It offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavoured malt beverages. The company also provides Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as ready to drink and non-alcoholic products. It provides its products primarily under the Johnnie Walker, Guinness, Tanqueray, Baileys, Smirnoff, Captain Morgan, Crown Royal, Don Julio, Cîroc, Buchanan's, Casamigos, J&B, and Ketel One brands. The company operates in the United States, the United Kingdom, Turkey, Australia, Korea, India, Greater China, Brazil, Mexico, South Africa, Nigeria, and internationally. Diageo plc was incorporated in 1886 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, Diageo has a trailing twelve months EPS of $8.17.
PE Ratio
Diageo has a trailing twelve months price to earnings ratio of 18.54. Meaning, the purchaser of the share is investing $18.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 40.05%.
More news about Diageo.
7. Eastern Company (EML) – Dividend Yield: 2.44%
Eastern Company’s last close was $18.14, 25.5% under its 52-week high of $24.35. Intraday change was 0.44%.
The Eastern Company designs, manufactures, and sells engineered solutions to industrial markets in the United States and internationally. It offers turnkey returnable packaging solutions that are used in the assembly process of vehicles, aircraft, and durable goods, as well as in the production process of plastic packaging products, packaged consumer goods, and pharmaceuticals; designs and manufactures blow mold tools and injection blow mold tooling products, and 2-step stretch blow molds and related components; and supplies blow molds and change parts to the food, beverage, healthcare, and chemical industry. It also offers rotary latches, compression latches, draw latches, hinges, camlocks, key switches, padlocks, and handles, as well as development and program management services for custom electromechanical and mechanical systems; designs and manufactures proprietary vision technology for original equipment manufacturers (OEMs) and aftermarket applications; and provides aftermarket components to the heavy-duty truck market. The Eastern Company was founded in 1858 and is based in Naugatuck, Connecticut.
Earnings Per Share
As for profitability, Eastern Company has a trailing twelve months EPS of $1.07.
PE Ratio
Eastern Company has a trailing twelve months price to earnings ratio of 16.95. Meaning, the purchaser of the share is investing $16.95 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.41%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 1.7%, now sitting on 281.54M for the twelve trailing months.
More news about Eastern Company.
8. Abbott Laboratories (ABT) – Dividend Yield: 2.11%
Abbott Laboratories’s last close was $96.88, 16.36% below its 52-week high of $115.83. Intraday change was 0.9%.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Earnings Per Share
As for profitability, Abbott Laboratories has a trailing twelve months EPS of $2.93.
PE Ratio
Abbott Laboratories has a trailing twelve months price to earnings ratio of 33.13. Meaning, the purchaser of the share is investing $33.13 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.93%.
More news about Abbott Laboratories.
9. Flowserve Corporation (FLS) – Dividend Yield: 2.05%
Flowserve Corporation’s last close was $38.78, 5.46% below its 52-week high of $41.02. Intraday change was -0.08%.
Flowserve Corporation designs, develops, manufactures, distributes, and services industrial flow management equipment in the United States, Europe, the Middle East, Africa, Asia, and internationally. It operates in two segments, Flowserve Pump Division (FPD) and Flow Control Division (FCD). The FPD segment offers custom and pre-configured pumps and pump systems, mechanical seals, auxiliary systems, replacement parts, upgrades, and related aftermarket services, including installation and commissioning services, seal systems spare parts, repairs, advanced diagnostics, re-rate and upgrade solutions, retrofit programs, and machining and asset management solutions, as well as manufactures a gas-lubricated mechanical seal for use in high-speed compressors for gas pipelines. The FCD segment provides engineered and industrial valve and automation solutions, including isolation and control valves, actuation, controls, and related equipment, as well as equipment maintenance services for flow control systems, including advanced diagnostics, repair, installation, commissioning, retrofit programs, and field machining capabilities. This segment's products are used to control, direct, and manage the flow of liquids, gases, and fluids. The company primarily serves oil and gas, chemical and pharmaceuticals, power generation, and water management markets, as well as general industries, including mining and ore processing, pulp and paper, food and beverage, and other smaller applications. The company distributes its products through direct sales, distributors, and sales representatives. Flowserve Corporation was incorporated in 1912 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Flowserve Corporation has a trailing twelve months EPS of $1.81.
PE Ratio
Flowserve Corporation has a trailing twelve months price to earnings ratio of 21.43. Meaning, the purchaser of the share is investing $21.43 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.64%.
More news about Flowserve Corporation.
